[go: up one dir, main page]

EP0307352B1 - Container for medicaments - Google Patents

Container for medicaments Download PDF

Info

Publication number
EP0307352B1
EP0307352B1 EP88810523A EP88810523A EP0307352B1 EP 0307352 B1 EP0307352 B1 EP 0307352B1 EP 88810523 A EP88810523 A EP 88810523A EP 88810523 A EP88810523 A EP 88810523A EP 0307352 B1 EP0307352 B1 EP 0307352B1
Authority
EP
European Patent Office
Prior art keywords
pack
push
medicament container
container according
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP88810523A
Other languages
German (de)
French (fr)
Other versions
EP0307352A1 (en
Inventor
Eileen Dixon
Robert Bänziger
René Hildenbrand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Priority to AT8888810523T priority Critical patent/ATE104540T1/en
Publication of EP0307352A1 publication Critical patent/EP0307352A1/en
Application granted granted Critical
Publication of EP0307352B1 publication Critical patent/EP0307352B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D5/00—Rigid or semi-rigid containers of polygonal cross-section, e.g. boxes, cartons or trays, formed by folding or erecting one or more blanks made of paper
    • B65D5/42—Details of containers or of foldable or erectable container blanks
    • B65D5/44—Integral, inserted or attached portions forming internal or external fittings
    • B65D5/50—Internal supporting or protecting elements for contents
    • B65D5/5002—Integral elements for containers having tubular body walls
    • B65D5/5011—Integral elements for containers having tubular body walls formed by folding inwardly of extensions hinged to the upper or lower edges of the body
    • B65D5/5014—Integral elements for containers having tubular body walls formed by folding inwardly of extensions hinged to the upper or lower edges of the body and with an integral end closure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/04—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, spherical or like small articles, e.g. tablets or pills
    • B65D83/0445—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments
    • B65D83/0463—Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments formed in a band or a blisterweb, inserted in a dispensing device or container

Definitions

  • the invention relates to a medicament container, in particular one for transdermal patches and other single-dose dosage forms.
  • transdermal patches are dosage forms that release medication slowly and constantly through the skin.
  • a known patch contains an estrogen such as e.g. in GB-A-2 093 694. It delivers estrogen transdermally bypassing the liver, i.e. the "first pass" effect of liver metabolism is avoided.
  • patients using such patches should take a progestogen tablet at the same time. For example, the patient may need 8 patches and 12 tablets over a 28 day period. When tablets and patches are delivered separately, it is difficult to remember and to know when to take a new patch and when to take a tablet.
  • the aim of the invention is to create a container which enables the patient to ensure "synchronous" treatment with plasters and to take e.g. Tablets relieved.
  • single dose dosage forms include To understand capsules made of hard or flexible gelatin, ampoules, suppositories etc.
  • DE-A-27 14 420 describes a collapsible, one-piece medicament container which has two places for medicaments of one and the same medicament dosage form. Both places are designed to take pills, especially daily doses of an anti-conception agent for men and women.
  • the container In the folded state, the container is designed to be open at its two longitudinal ends, so that the space between the two places for the pills is also unsuitable for the safe reception of another pharmaceutical dosage form, since this would fall out of the container through the openings.
  • FIGS. 2 and 3 The box of FIGS. 2 and 3 is formed from the "blank" shown in FIG. 1a and the push-through pack 41 shown in FIG. 1b. For this purpose, the blank is folded around the folds indicated by dash-dotted lines.
  • the push-through pack 41 of FIG. 1b is interposed.
  • the holes 35 of the parts 32 and 34 are mirror images of each other.
  • the tablet containers 42 have a pattern congruent with the holes 35, so that the tablet containers and thus the tablets can be placed exactly in the holes 35.
  • the fields 32 and 34 are glued (cardboard) or welded (plastic) to one another or to the interposed push-through pack 41, depending on the material.
  • a detachable adhesive and / or plug connection can also be selected, which enables an exchange or replacement of the (used) push-through pack.
  • the pack can then be used for several treatment cycles.
  • Adhesives are used which, on the one hand, only impart a limited adhesive force and, on the other hand, enable the parts to be loosened and glued several times.
  • the fields 12 and 14 form the finished box the rear and front wall of the pocket 10, the fields 16 and 18 each a side wall, the field 20 the bottom and the fields 23 and 36 the cover.
  • the fields 22, 24, 26 and 28 form connecting lugs.
  • the field 38 forms a tab.
  • the tabs 24 and 26 are first folded onto the side wall panels 16 and 18. Then folds are carried out around the corresponding folds at an angle of 90 ° (perpendicular to the plane of the blank) in the order of flap 28 - bottom 20 - flap 22 - side wall 18 - front wall 14 - side wall 16.
  • the tabs 28 and 22 come to lie on the rear wall and are glued or welded to it.
  • the two tabs 24 and 26 in the pocket 10 can now be pressed onto the bottom 20. They prevent a gap from forming between the side walls 16, 18 and the bottom 20.
  • the pocket 10 is closed by the part 30 with the tablet containers 42 being folded down onto the cover 36 and the latter subsequently by 180 °. In this position, the cover is secured against inadvertent opening by inserting the plug-in tab 38 into the slot 40 in its closed position.
  • the pocket 10 receives the number of plasters that are required for a treatment cycle, as well as an instruction leaflet with all the necessary information about the medication and its intake.
  • the cover 36 can additionally be printed on short-term intake instructions or contain an adhesive label which makes it easier for the patient to synchronize the intake of medication, for example when to use a plaster and when to take a tablet. This type of connection of information and container has the advantage that it is not lost can. Additional instructions, such as 1st day, 2nd day etc., can also be printed on the part 30 carrying the blister pack associated with the tablet containers 12.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Packages (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)

Abstract

The container for medicaments comprises two spaces for receiving medicaments of two different types of administration. The first space is formed by a bag (10) for receiving, for example, transdermal plasters. The second space contains a press-through package (41), which is fixed in the manner of a sandwich between two parts (32, 34) of the box, with individual dosage containers (42). <IMAGE>

Description

Die Erfindung betrifft ein Arzneimittelbehältnis, insbesondere ein solches für transdermale Pflaster und andere Einzelsdosis-Darreichungsformen.The invention relates to a medicament container, in particular one for transdermal patches and other single-dose dosage forms.

Transdermale Pflaster sind bekanntlich Darreichungsformen, die Medikamente langsam und konstant durch die Haut hindurch freisetzen. Ein solches bekanntes Pflaster enthält ein Oestrogen wie z.B. in der GB-A-2 093 694 beschrieben ist. Es liefert Oestrogen transdermal unter Umgehung der Leber, d.h. der "First-Pass"-Effekt des Lebermetabolismus wird vermieden. Vorzugsweise sollten Patienten, die solche Pflaster benutzen, zur gleichen Zeit Tabletten mit einem Gestagen einnehmen. Zum Beispiel kann der Patient während einer Periode von 28 Tagen 8 Pflaster und 12 Tabletten benötigten. Wenn Tabletten und Pflaster getrennt geliefert werden, ist es schwer, sich zu erinnern und zu wissen, wann ein neues Pflaster und wann eine Tablette einzunehmen ist.As is well known, transdermal patches are dosage forms that release medication slowly and constantly through the skin. Such a known patch contains an estrogen such as e.g. in GB-A-2 093 694. It delivers estrogen transdermally bypassing the liver, i.e. the "first pass" effect of liver metabolism is avoided. Preferably, patients using such patches should take a progestogen tablet at the same time. For example, the patient may need 8 patches and 12 tablets over a 28 day period. When tablets and patches are delivered separately, it is difficult to remember and to know when to take a new patch and when to take a tablet.

Durch die Erfindung soll ein Behältnis geschaffen werden, welches dem Patienten die Sicherstellung der "synchronen" Behandlung mit Pflastern und die Einnahme von z.B. Tabletten erleichtert.The aim of the invention is to create a container which enables the patient to ensure "synchronous" treatment with plasters and to take e.g. Tablets relieved.

Diese Aufgabe wird erfindungsgemäss durch die Ausbildung des Behältnisses gemäss Patentanspruch 1 gelöst. Ausser Tabletten sind unter EinzeldosisDarreichungsformen u.a. Kapseln aus harter oder flexibler Gelatine, Ampullen, Zäpfchen etc. zu verstehen.This object is achieved according to the invention by designing the container according to claim 1. In addition to tablets, single dose dosage forms include To understand capsules made of hard or flexible gelatin, ampoules, suppositories etc.

Eine Vielzahl von Blisterpackungen oder Schachteln sind in den Patentschriften GB-A-689 631, DE-A-1 803 236, US-A- 1,474,248, DE-A-2 516 720, DE-A-2 714 420, CH-A-516 450, und EP-A-210 820 beschrieben. Keine dieser Patentschriften offenbart die Kombination einer Blisterpackung mit einer Tasche für transdermale Pflaster.A variety of blister packs or boxes are described in GB-A-689 631, DE-A-1 803 236, US-A-1,474,248, DE-A-2 516 720, DE-A-2 714 420, CH-A -516 450, and EP-A-210 820. None of these patents disclose the combination of a blister pack with a pocket for transdermal patches.

In der DE-A-27 14 420 ist ein zusammenfaltbares einteiliges Arzneimittelbehältnis beschrieben, welches zwei Plätze für Arzneimittel ein und derselben Arzneimittel-Darreichungsform aufweist. Beide Plätze sind zur Aufnahme von Pillen, insbesondere von Tagesdosen eines Antikonzeptionsmittels für den Mann und für die Frau getrennt, ausgebildet. Im zusammengefalteten Zustand ist das Behältnis an seinen beiden Längsenden offen ausgebildet, so dass sich auch der Raum zwischen den beiden Plätzen für die Pillen nicht für die sichere Aufnahme einer anderen Arzneimittel-Darreichungsform eignet, da diese durch die Oeffnungen aus dem Behältnis fallen würde.DE-A-27 14 420 describes a collapsible, one-piece medicament container which has two places for medicaments of one and the same medicament dosage form. Both places are designed to take pills, especially daily doses of an anti-conception agent for men and women. In the folded state, the container is designed to be open at its two longitudinal ends, so that the space between the two places for the pills is also unsuitable for the safe reception of another pharmaceutical dosage form, since this would fall out of the container through the openings.

Im folgenden wird die Erfindung anhand eines in den Figuren dargestellten Ausführungsbeispiels in Form einer Schachtel näher erläutert; es zeigen

  • Fig. 1a einen Zuschnitt der Schachtel in Aufsicht,
  • Fig. 1b eine Durchdrückpackung in perspektivischer Darstellung,
  • Fig. 2 eine perspektivische Darstellung der offenen Schachtel und
  • Fig. 3 eine perspektivische Darstellung der geschlossenen Schachtel.
The invention is explained in more detail below on the basis of an exemplary embodiment shown in the figures in the form of a box; show it
  • 1a shows a cut of the box in supervision,
  • 1b is a push-through pack in a perspective view,
  • Fig. 2 is a perspective view of the open box and
  • Fig. 3 is a perspective view of the closed box.

Die Schachtel der Fig. 2 bzw. 3 wird aus dem in Fig. 1a dargestellten "Zuschnitt" und der in Fig. 1b gezeigten Durchdrückpackung 41 gebildet. Hierzu wird der Zuschnitt um die durch strich-punktierte Linien angedeuteten Falze entsprechend gefaltet.The box of FIGS. 2 and 3 is formed from the "blank" shown in FIG. 1a and the push-through pack 41 shown in FIG. 1b. For this purpose, the blank is folded around the folds indicated by dash-dotted lines.

Vor der Zusammenfaltung der Teile 32 und 34 um die Falzlinie 33 wird die Durchdrückpackung 41 der Fig. 1b zwischengelegt. Die Löcher 35 der Teile 32 und 34 sind spiegelbildlich zueinander. Die Tablettenbehältnisse 42 weisen ein mit den Löchern 35 deckungsgleiches Muster auf, so dass die Tablettenbehältnisse und damit die Tabletten genau in die Löcher 35 gesetzt werden können. Nach dem Zusammenfalten werden die Felder 32 und 34 miteinander bzw. mit der zwischengelegten Durchdrückpackung 41 je nach Material verklebt (Karton) oder verschweisst (Kunststoff). Es kann auch eine lösbare Kleb- und/oder Steck-Verbindung gewählt werden, was einen Austausch bzw. Ersatz der (verbrauchten) Durchdrückpackung ermöglicht. Die Packung kann dann für mehrere Behandlungszyklen verwendet werden. Zur Herstellung lösbarer Klebverbindungen werden Klebstoffe verwendet, welche einerseits nur eine begrenzte Haftkraft vermitteln und anderseits ein mehrmaliges Lösen und Zusammenkleben der Teile ermöglichen.Before the parts 32 and 34 are folded together about the fold line 33, the push-through pack 41 of FIG. 1b is interposed. The holes 35 of the parts 32 and 34 are mirror images of each other. The tablet containers 42 have a pattern congruent with the holes 35, so that the tablet containers and thus the tablets can be placed exactly in the holes 35. After folding, the fields 32 and 34 are glued (cardboard) or welded (plastic) to one another or to the interposed push-through pack 41, depending on the material. A detachable adhesive and / or plug connection can also be selected, which enables an exchange or replacement of the (used) push-through pack. The pack can then be used for several treatment cycles. For the production of detachable adhesive connections Adhesives are used which, on the one hand, only impart a limited adhesive force and, on the other hand, enable the parts to be loosened and glued several times.

Die Felder 12 und 14 bilden der fertigen Schachtel die Hinter- und die Vorderwand der Tasche 10, die Felder 16 und 18 je eine Seitenwand, das Feld 20 den Boden und die Felder 23 und 36 den Verschlussdeckel. Die Felder 22, 24, 26 und 28 bilden Verbindungslaschen. Das Feld 38 bildet eine Stecklasche.The fields 12 and 14 form the finished box the rear and front wall of the pocket 10, the fields 16 and 18 each a side wall, the field 20 the bottom and the fields 23 and 36 the cover. The fields 22, 24, 26 and 28 form connecting lugs. The field 38 forms a tab.

Zur Formung der Tasche 10 werden zunächst die Laschen 24 und 26 auf die Seitenwandfelder 16 und 18 gefaltet. Danach werden Faltungen um die entsprechenden Falze jeweils im Winkel von 90° (senkrecht zur Ebene des Zuschnitts) nach oben in der Reihenfolge Lasche 28 - Boden 20 - Lasche 22 - Seitenwand 18 - Vorderwand 14 - Seitenwand 16 durchgeführt. Die Laschen 28 und 22 kommen dabei auf die Rückwand zu liegen und werden mit dieser verklebt oder verschweisst. Die beiden Laschen 24 und 26 in der Tasche 10 können jetzt auf den Boden 20 gedrückt werden. Sie verhindern, dass sich zwischen den Seitenwänden 16, 18 und dem Boden 20 ein Spalt bildet.To form the pocket 10, the tabs 24 and 26 are first folded onto the side wall panels 16 and 18. Then folds are carried out around the corresponding folds at an angle of 90 ° (perpendicular to the plane of the blank) in the order of flap 28 - bottom 20 - flap 22 - side wall 18 - front wall 14 - side wall 16. The tabs 28 and 22 come to lie on the rear wall and are glued or welded to it. The two tabs 24 and 26 in the pocket 10 can now be pressed onto the bottom 20. They prevent a gap from forming between the side walls 16, 18 and the bottom 20.

Die Tasche 10 wird geschlossen, indem das Teil 30 mit den Tablettenbehältnissen 42 auf den Deckel 36 und letzterer anschliessend um 180° nach unten geklappt wird. In dieser Stellung ist der Deckel durch Einschieben der Stecklasche 38 in den Schlitz 40 in seiner Schliesstellung gegen unbeabsichtigtes Oeffnen gesichert.The pocket 10 is closed by the part 30 with the tablet containers 42 being folded down onto the cover 36 and the latter subsequently by 180 °. In this position, the cover is secured against inadvertent opening by inserting the plug-in tab 38 into the slot 40 in its closed position.

Die Tasche 10 nimmt die Anzahl von Pflastern auf, die für einen Behandlungszyklus benötigt werden, sowie einen Beipackzettel mit allen nötigen Angaben über die Medikamente sowie deren Einnahme. Der Deckel 36 kann zusätzlich Einnahmehinweise in Kurzform aufgedruckt oder durch eine aufgeklebte Etikette enthalten, die dem Patienten die Synchronisation der Einnahme der medikamente erleichtern, wann z.B. ein Pflaster zu verwenden und wann eine Tablette einzunehmen ist. Diese Art der Verbindung von Information und Behältnis hat den Vorteil, dass sie nicht verloren gehen kann. Zusätzliche Hinweise, wie z.B. 1. Tag, 2. Tag usw. können auch auf dem die Durchdrückpackung tragenden Teil 30 den Tablettenbehältnissen 12 zugeordnet aufgedruckt sein.The pocket 10 receives the number of plasters that are required for a treatment cycle, as well as an instruction leaflet with all the necessary information about the medication and its intake. The cover 36 can additionally be printed on short-term intake instructions or contain an adhesive label which makes it easier for the patient to synchronize the intake of medication, for example when to use a plaster and when to take a tablet. This type of connection of information and container has the advantage that it is not lost can. Additional instructions, such as 1st day, 2nd day etc., can also be printed on the part 30 carrying the blister pack associated with the tablet containers 12.

Claims (10)

  1. A medicament container for the simultaneous accommodation of two different medicaments, containing one medicament in the form of individual doses in a push-through pack (41), wherein the container is configured as a box with folding lid (36), the push-through pack (41) being fastened to an inwardly foldable part (30), connected to the folding lid, in such a way that the individual doses can easily be removed from the push-through pack, and wherein the box forms a pocket (10) which can be closed by the folding lid and is intended for accommodating transdermal plasters.
  2. A medicament container according to claim 1, wherein the push-through pack (41) can (after use) be exchanged.
  3. A medicament container according to claim 1 or 2, wherein the inwardly foldable part (30) is articulated with the push-through pack (41) at the front free edge of the folding lid.
  4. A medicament container according to one of claims 1 to 3, wherein the inwardly foldable part with the push-through pack (41) is formed itself by two parts (32, 34) which can be folded together and which have holes (35) which are arranged in a "pattern" congruent with the individual dose containers (42) of the push-through pack (41), and wherein the push-through pack is held tightly in sandwich form between these parts (32, 34).
  5. A medicament container according to claim 4, wherein the "sandwich" consisting of the two folding parts (32, 34) and the push-through pack (41) is glued by means of an adhesive which has limited adhesion.
  6. A medicament container according to claim 5, wherein, to the extent that the folding parts (32, 34) are coated with adhesive, this coating makes it possible to stick them together and detach them repeatedly.
  7. A medicament container according to claims 4 to 6, wherein the parts (32, 34) which can be stuck together each have 12 holes (35).
  8. A medicament container according to one of claims 1 to 7, wherein the folding lid (36) can be fixed in its closed position by a tab (38) which can be inserted into a slit (40).
  9. A medicament container according to one of claims 1 to 8, wherein information on use is printed on the inside of the folding lid, or a sticker provided with this information is attached.
  10. A medicament container according to one of claims 1 to 9, wherein the box is formed from a single integral blank (Fig. 1a) and a push-through pack (Fig. 1b).
EP88810523A 1987-08-07 1988-07-29 Container for medicaments Expired - Lifetime EP0307352B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT8888810523T ATE104540T1 (en) 1987-08-07 1988-07-29 MEDICATION CONTAINER.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8718797 1987-08-07
GB878718797A GB8718797D0 (en) 1987-08-07 1987-08-07 Container

Publications (2)

Publication Number Publication Date
EP0307352A1 EP0307352A1 (en) 1989-03-15
EP0307352B1 true EP0307352B1 (en) 1994-04-20

Family

ID=10621998

Family Applications (1)

Application Number Title Priority Date Filing Date
EP88810523A Expired - Lifetime EP0307352B1 (en) 1987-08-07 1988-07-29 Container for medicaments

Country Status (14)

Country Link
EP (1) EP0307352B1 (en)
JP (1) JP2791477B2 (en)
AT (1) ATE104540T1 (en)
AU (1) AU626267B2 (en)
CA (1) CA1331167C (en)
DE (1) DE3889178D1 (en)
DK (1) DK173959B1 (en)
ES (1) ES2051313T3 (en)
FI (1) FI92679C (en)
GB (1) GB8718797D0 (en)
NO (1) NO177586C (en)
NZ (1) NZ225699A (en)
PT (2) PT88163A (en)
ZA (1) ZA885770B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2256853B (en) * 1991-06-20 1994-10-12 Imp Pharmaceutical Services Li A packaging device for blister packaged pills
JPH0556141U (en) * 1991-12-27 1993-07-27 大日本製薬株式会社 Drug holder
JPH0633935Y2 (en) * 1992-03-27 1994-09-07 サカセ化学工業株式会社 Grouping Medicine Pool
DE4429503C2 (en) * 1994-08-19 2003-09-18 Astrazeneca Ab Package, especially pharmaceutical package
EP0725015A1 (en) * 1995-02-04 1996-08-07 BIOMEDICA ARZNEIMITTEL GmbH &amp; Co. KG Package for tablets contained in a blister pack
DE19831263A1 (en) 1998-07-11 2000-01-13 Lohmann Therapie Syst Lts Pharmaceutical form
DE19855318C1 (en) * 1998-12-01 2000-04-20 Lohmann Therapie Syst Lts Packaging unit for two different medicaments for joint use comprises an additional foldable flap element with rows of holes for accommodation capsules in blister packages
JP4802404B2 (en) * 2001-06-26 2011-10-26 凸版印刷株式会社 Portable drug folder
WO2003010066A1 (en) * 2001-07-26 2003-02-06 Novo Nordisk A/S A package for blister pack strips and a blank for the manufacturing of a package
WO2004090955A1 (en) * 2003-04-04 2004-10-21 Nikon Corporation Illuminating optical device, projection exposure system and exposure method
EP1481913A1 (en) 2003-05-26 2004-12-01 Dividella AG Child-resistant package
ITMI20042194A1 (en) * 2004-11-16 2005-02-16 Gi Bi Effe Srl DEVICE FOR SELECTIVE DELIVERY OF SOLID PRODUCTS FROM A BLISTER HOLDED BY THE SAME DEVICE

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1474248A (en) * 1922-03-29 1923-11-13 English Arthur Container for coloring-agent capsules
GB689631A (en) * 1950-02-10 1953-04-01 Rose Brothers Ltd Improvements in cartons, boxes and like containers
DE1803236A1 (en) * 1968-10-11 1970-05-14 Arne Larsson Box for gifts, preferably for confectionery
CH516450A (en) * 1970-10-20 1971-12-15 Buergi Xaver Packaging for tablets or pills
DE2516720A1 (en) * 1975-04-16 1976-10-28 Braun Ag Small goods twin section packaging unit - one sections containing the goods and the other in pull out form, used for contents information
DE2714420A1 (en) * 1976-06-01 1977-12-08 Int Pregnancy Advisory Service Contraceptive compsns. contg. gestagens - for admin. to both male and female
JPS6190718U (en) * 1984-11-16 1986-06-12
GB8518828D0 (en) * 1985-07-25 1985-08-29 American Home Prod Tablet package
JPS643638U (en) * 1987-06-27 1989-01-11

Also Published As

Publication number Publication date
EP0307352A1 (en) 1989-03-15
DK439288D0 (en) 1988-08-05
ATE104540T1 (en) 1994-05-15
FI92679C (en) 1994-12-27
FI883657L (en) 1989-02-08
FI883657A0 (en) 1988-08-05
ZA885770B (en) 1989-03-29
NO883494L (en) 1989-02-08
AU2043088A (en) 1989-02-09
PT88163A (en) 1989-06-30
NO177586B (en) 1995-07-10
GB8718797D0 (en) 1987-09-16
DK173959B1 (en) 2002-03-11
NZ225699A (en) 1990-06-26
JP2791477B2 (en) 1998-08-27
CA1331167C (en) 1994-08-02
NO883494D0 (en) 1988-08-05
JPS6470058A (en) 1989-03-15
DK439288A (en) 1989-02-08
FI92679B (en) 1994-09-15
ES2051313T3 (en) 1994-06-16
PT8859T (en) 1994-02-28
AU626267B2 (en) 1992-07-30
DE3889178D1 (en) 1994-05-26
NO177586C (en) 1995-10-18

Similar Documents

Publication Publication Date Title
DE69422683T2 (en) Packaging for contact lenses
EP1947027B1 (en) Blister packages and method of temporary storage of products
DE69618375T2 (en) Packaging and device for their manufacture
DE60310144T2 (en) SUPPLY VESSEL
DE4429503C2 (en) Package, especially pharmaceutical package
EP0307352B1 (en) Container for medicaments
DE202004021140U1 (en) Medicine pack has blister units with blister strip connected to protective case capable to be unfolded or opened out, and outer package for receiving the blister units and configured so that pack content is fixed in outer package inside
EP1196333A1 (en) Child-proof packaging for tablets
DE69719760T2 (en) CARDBOARD AND CUTTING FOR THEIR PRODUCTION
DE2920162A1 (en) BLISTER PACKAGING
AT517896B1 (en) Medication system with a medication tray and method for creating a delivery-ready medication system
EP1898863A1 (en) Case for accommodating a medicament pack, and use thereof
DE69400623T2 (en) Folding box with a reclosable opening
DE2226071A1 (en) BOWL-SHAPED CONTAINER WITH PARTITION WALL
DE69009151T2 (en) Packaging, in particular for pharmaceuticals, and processes for producing this packaging.
DE60011888T2 (en) LABELS AND LABELED PACKAGING
DE3840080A1 (en) Package for articles of small dimensions, such as tablets, pills, sweets and the like
DE60300075T2 (en) dispensing container
EP1135299A1 (en) Packing means for medicaments in the form of a folded box combination for at least two different primary packings
EP4000586A1 (en) Medicament container, kit for forming a medicament container and method for providing a medicament container
DE1915011A1 (en) Quick-opening distribution pack
DE3533683A1 (en) WARENTRAY AND DEDICATED CUTTING
DE202019102748U1 (en) Drug dispensers made of pulp
DE8814793U1 (en) Packaging for small-sized goods such as tablets, pills, candies, etc.
CH570907A5 (en) Sensitive item sheet packing - has pull-off flexible sheet attached to rigid one forming pockets

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19880801

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE ES FR GB GR IT LI NL SE

17Q First examination report despatched

Effective date: 19901001

ITTA It: last paid annual fee
GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE ES FR GB GR IT LI NL SE

REF Corresponds to:

Ref document number: 104540

Country of ref document: AT

Date of ref document: 19940515

Kind code of ref document: T

ET Fr: translation filed
REF Corresponds to:

Ref document number: 3889178

Country of ref document: DE

Date of ref document: 19940526

GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 19940505

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2051313

Country of ref document: ES

Kind code of ref document: T3

REG Reference to a national code

Ref country code: GR

Ref legal event code: FG4A

Free format text: 3011567

ITF It: translation for a ep patent filed
EAL Se: european patent in force in sweden

Ref document number: 88810523.6

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
REG Reference to a national code

Ref country code: CH

Ref legal event code: PFA

Free format text: CIBA-GEIGY AG TRANSFER- NOVARTIS AG

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

NLS Nl: assignments of ep-patents

Owner name: NOVARTIS AG

REG Reference to a national code

Ref country code: FR

Ref legal event code: TP

REG Reference to a national code

Ref country code: ES

Ref legal event code: PC2A

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20020603

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20020604

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20020610

Year of fee payment: 15

Ref country code: CH

Payment date: 20020610

Year of fee payment: 15

Ref country code: SE

Payment date: 20020610

Year of fee payment: 15

Ref country code: DE

Payment date: 20020610

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GR

Payment date: 20020613

Year of fee payment: 15

Ref country code: AT

Payment date: 20020613

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20020702

Year of fee payment: 15

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030729

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030730

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030730

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030731

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030731

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030731

BERE Be: lapsed

Owner name: *NOVARTIS A.G.

Effective date: 20030731

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040203

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040205

EUG Se: european patent has lapsed
REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040331

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20040201

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20030730

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20050729

APAH Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNO

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20070725

Year of fee payment: 20

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20080728

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20080728